B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

OAZ1

MOLECULAR TARGET

ornithine decarboxylase antizyme 1

UniProt: P54368NCBI Gene: 49461 compounds

OAZ1 (ornithine decarboxylase antizyme 1) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting OAZ1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Spermine0.691

About OAZ1 as a Drug Target

OAZ1 (ornithine decarboxylase antizyme 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented OAZ1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

OAZ1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.